Back to search

National and Kapodistrian University of Athens

Επίδραση της συστηματικής χορήγησης bevacizumab στην καρδιοαγγειακή πρόγνωση ογκολογικών ασθενών

Abstract

dc:description

Bevacizumab is an antibody against VEGF, widely used in the treatment of cancer. Aim of the present study is the evaluation of its impact in the cardiovascular prognosis of cancer patients.A sample of 147 patients suffering from metastatic breast or colorectal cancer were staged and planned to receive first line therapy of conventional chemo, with the addition of bevacizumab or not, according to the discretion of the oncologist. All patients were evaluated before the initiation of the therapy, at 6 and 18 months after the end of it. The 18-month estimate for freedom from cardiovascular event was 88.4±4.1% for bevacizumab and 98.6±1.4% for the controls (p=0.05). All cardiovascular events were myocardial infarctions and were significantly higher in the bevacizumab group compared to the control group (9.21% versus 1.40%, p=0.03). Multivariate analysis showed that the use of bevacizumab and the presence of LBBB and the use of bevacizumab were the only independent predictors of cardiovascular events (p<0.001).Regarding echocardiographic evaluation, the Sa wave, the index evaluating the systolic function of myocardium, was significantly lower at 6 months (10.93±4.64 versus 9.90±3.59 cm/s, p=0.0007), and remained significantly lower at 18 months (10.93±4.64 versus 9.03±9.56 cm/s, p=0.003). Regarding measurements evaluating the diastolic function, E/E ratio significantly increased both at 6 months (5.83±2.53 versus 7.86±3.45, p=0.0005), and at 18 months follow up (5.83±2.53 versus 7.84±3.45, p=0.004).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Michelongona, Archontoula
  • Μιχελόγγονα, Αρχοντούλα

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42481

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Michelongona, Archontoula; Μιχελόγγονα, Αρχοντούλα. Επίδραση της συστηματικής χορήγησης bevacizumab στην καρδιοαγγειακή πρόγνωση ογκολογικών ασθενών. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42481